1FW1 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - WuXi Biologics (Cayman) Inc

Watchlist Manager

Watchlist

Price: 10.9 EUR Market Closed

Market Cap: €22.7B

	WuXi Biologics (Cayman) Inc F:1FW1	CN
	SGS SA SIX:SGSN	CH
U	UMH Properties Inc SWB:WXE	US
B	Brixmor Property Group Inc F:BXR	US
	APA Corp (US) NASDAQ:APA	US
I	IMPACT Growth Real Estate Investment Trust SET:IMPACT	TH
	SoFi Technologies Inc MIL:1SOFI	US
	Raytron Technology Co Ltd SSE:688002	CN
	Roper Technologies Inc SIX:ROP	US
	Keyence Corp TSE:6861	JP
	BHP Group Ltd ASX:BHP	AU
L	Lubelski Wegiel Bogdanka SA SWB:UXX	PL
	Grupo Aeroportuario del Pacifico SAB de CV BMV:GAPB	MX
C	Commerzbank AG DUS:CBK	DE

Profitability Summary

WuXi Biologics (Cayman) Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

47%

Sustainable 3Y Average Gross Margin

43%

Gross Margin is Increasing

42% > 47%

Exceptional Operating Margin

31%

Sustainable 3Y Average Operating Margin

27%

Operating Margin is Increasing

26% > 31%

Healthy Net Margin

21%

Sustainable 3Y Average Net Margin

20%

Declining Net Margin

25% > 21%

Exceptional Free Cash Flow Margin

11%

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

Positive 3Y Average ROIC

10%

ROIC is Increasing

9% > 13%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.